OTCM
MDCE
Market cap2mUSD
Apr 04, Last price
0.00USD
1D
14.29%
1Q
-65.22%
Jan 2017
700.00%
IPO
14.29%
Name
Medical Care Technologies Inc
Chart & Performance
P/E
—
P/S
3.62
EPS
—
Div Yield, %
—
Shrs. gr., 5y
413.16%
Rev. gr., 5y
%
Revenues
732k
-78.90%
Net income
-388k
L
CFO
30k
-78.56%
Profile
Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other merchandise, including over-the-counter medicines, herbal products, personal care products, and family care products. It serves retail pharmacies, pharmaceutical companies, hospitals, physicians' office practices, and consumers; and industrial and food microbiology laboratories. The company offers its products through its pediatric health and wellness centers, Website, and retail pharmacies, as well as through sales and distribution channels, and directly to end-users through independent sales representatives. Medical Care Technologies Inc. was founded in 2007 and is headquartered in Beijing, China.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 732 -78.90% | 3,470 | |||
Cost of revenue | 1,113 | 2,139 | |||
Unusual Expense (Income) | |||||
NOPBT | (381) | 1,330 | |||
NOPBT Margin | 38.34% | ||||
Operating Taxes | (228) | ||||
Tax Rate | |||||
NOPAT | (381) | 1,559 | |||
Net income | (388) -135.24% | 1,099 | |||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | 39 | 28 | |||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | 4 | 16 | |||
| Cash flow | |||||
Cash from operating activities | 30 | 140 | |||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | (6) | (128) | |||
FCF | 19 | 621 | |||
| Balance | |||||
Cash | 35 | 12 | |||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | (10,778) | (10,391) | |||
Invested Capital | 11,351 | 11,340 | |||
ROIC | 13.65% | ||||
ROCE | 140.12% | ||||
| EV | |||||
Common stock shares outstanding | 3,209,575 | 3,209,575 | |||
Price | 0.00 -28.57% | 0.00 -82.77% | |||
Market cap | 6,419 -28.57% | 8,987 -81.31% | |||
EV | 6,423 | 9,003 | |||
EBITDA | (381) | 1,330 | |||
EV/EBITDA | 6.77 | ||||
Interest | 6 | ||||
Interest/NOPBT | |||||